PR Newswire

Presentation of in vitro studies of RM-0256, a novel anti-PD-L1 antibody conjugated to IR700, which comprises a dual mode of…

HOUSTON, Sept. 19, 2024 /PRNewswire/ -- Kawasaki Heavy Industries, Ltd. (Kawasaki) and CB&I, a wholly owned unrestricted subsidiary of McDermott, announced…

Zero carbon emission goal, development of eco-friendly clean fuel ammonia gas turbine technologyEstablishment of eco-friendly fuel conversion cooperation with a…

LAFAYETTE, La., Sept. 19, 2024 /PRNewswire/ -- Wright, Moore, DeHart, Dupuis & Hutchinson ("WMDDH") has become aware of a data security…

SUN VALLEY, Idaho, Sept. 19, 2024 /CNW/ - Sun Valley Gold LLC ("Sun Valley") announced today that it has disposed of…

TAIPEI, Sept. 19, 2024 /PRNewswire/ -- GEEKOM, a Taiwanese tech company also known as the Green Mini PC Global Leader,…

LIMASSOL, Cyprus, Sept. 19, 2024  /PRNewswire/ -- Ultima Markets, a leading global forex and CFDs brokerage, is thrilled to announce its…

Gen.G unveils Descente collaboration uniform, reflecting their belief in winning Worlds SEOUL, South Korea, Sept. 19, 2024 /PRNewswire/ -- Global…

PHOENIX, Sept. 19, 2024 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity" or the "Company"), a leading provider of diversified…

HIGHLIGHTS The US FDA has granted Fast Track Designation to Amplia's lead drug narmafotinib in advanced pancreatic cancerFast Track Designation…

NEW YORK, Sept. 19, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies…

Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking the third new indication for RYBREVANT®…